The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population

BACKGROUND: Non-adherence to antipsychotic medication in schizophrenic patients is common and associated with symptom relapse and poorer long-term outcomes. The risk factors for treatment non-adherence include dosing frequency and complexity. Besides, slower dose titration in an acute schizophrenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Pei-Yin, Lee, Meei-Shyuan, Yeh, Chin-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308905/
https://www.ncbi.nlm.nih.gov/pubmed/25609320
http://dx.doi.org/10.1186/s12888-014-0378-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308905/
https://www.ncbi.nlm.nih.gov/pubmed/25609320
http://dx.doi.org/10.1186/s12888-014-0378-5

Ejemplares similares